Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study

ABSTRACT Background Although neoadjuvant chemoimmunotherapy has emerged as a promising approach for resectable non‐small cell lung cancer (NSCLC), comparative real‐world data on different PD‐1 inhibitors are limited. This study compared the clinical efficacy, pathological response, survival, and saf...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Bo Yan, Xiaoxuan Sun, Yan Sheng, Ran Zhang, Yanjun Su, Yulong Chen
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Wiley 2025-07-01
Sraith:	Thoracic Cancer
Ábhair:	chemoimmunotherapy immune checkpoint inhibitors neoadjuvant therapy non‐small cell lung cancer surgery
Rochtain ar líne:	https://doi.org/10.1111/1759-7714.70123
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!